RAMSAY GENERALE DE SANTE SA Pharmaceuticals, Biotechnology & Life Sciences
$0.007
30 June 2023 at 3:17pm
High
$0.01Low
$0.01Trades
6Turnover
$9,683Volume
1,383,303
RAMSAY GENERALE DE SANTE SA
Pharmaceuticals, Biotechnology & Life Sciences
Quarterly Activities/Appendix 4C Cash Flow Report
RGS released this announcement to the ASX on 28 January 2022, 16:14. The announcement is marked as price sensitive, and is 8 page(s) in length and 396.89kb in size.
You can view all announcements from RGS and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RGS | |
|---|---|
| Ceasing to be a substantial holder | 15 June 2023, 12:45 |
| Change in substantial holding | 1 May 2023, 8:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 11:28 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 January 2022, 16:14 |
| Appointment of Board Advisor | 28 January 2022, 14:38 |
| Regeneus Market Update | 22 December 2021, 8:40 |
| Results of Annual General Meeting | 18 November 2021, 17:11 |
If you were already registered, log in here.
If you were already registered, log in here.